Compare Nasdaq Inc (NDAQ) vs Sana Biotechnology Inc (SANA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nasdaq Inc vs Sana Biotechnology Inc — how do they compare? Nasdaq Inc trades at $90.25 (market cap $51.96B), while Sana Biotechnology Inc trades at $3.17 (market cap $873.84M). The key difference: Nasdaq Inc is far larger — about 59.5× Sana Biotechnology Inc's market cap, and Nasdaq Inc pays a 1.22% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| NDAQ | SANA | |
|---|---|---|
Market Cap | $51.96B | $873.84M |
Sector | Financials | Health |
52-Week High | $100.98 | $5.92 |
52-Week Low | $76.85 | $2.68 |
Enterprise Value | $59.02B | $848.03M |
Dividend Yield | 1.22% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nasdaq Inc
Founded in 1971, Nasdaq is primarily known for its equity exchange, but in addition to its market-services business (about 35% of sales), the company sells and distributes market data as well as offers Nasdaq-branded indexes to asset managers and investors through its information-services segment (30%). Nasdaq's corporate-services business (20%) offers listing services and related investor relations products to publicly traded companies and through the company's market technology group (15%), Nasdaq facilitates the exchange operations of other exchanges throughout the world and provides financial compliance services.
Read more on NDAQ →About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →
